4.8 Article

Ultrasensitive High-Resolution Mass Spectrometric Analysis of a DNA Adduct of the Carcinogen Benzo[a]pyrene in Human Lung

Journal

ANALYTICAL CHEMISTRY
Volume 89, Issue 23, Pages 12735-12742

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acs.analchem.7b02856

Keywords

-

Funding

  1. U.S. National Institutes of Health/National Cancer Institute [CA-92025, R50-CA211256]
  2. U.S. National Institutes of Health/National Cancer Institute (Cancer Center Support Grant) [CA 77598]

Ask authors/readers for more resources

Benzo[a]pyrene (BaP), an archetypical poly cyclic aromatic hydrocarbon, is classified as carcinogenic to humans and is ubiquitous in the environment, as evident by the measurable levels of BaP metabolites in virtually. all human urine samples examined. BaP carcinogenicity is believed to occur mainly through its covalent modification of DNA, resulting in the formation of BPDE N-2-dG, an adduct formed between deoxyguanosine and a diol epoxide metabolite of BaP, with subsequent mutation of critical growth control genes. In spite of the liquid chromatography mass spectrometry (LC- MS)-based detection of BPDE N-2-dG in BaP-treated rodents, and indirectly through high-performance liquid chromatography (HPLC)-fluorescence detection of BaP-7,8,9,10-tetraols released from human DNA upon add hydrolysis, BPDE N-2-dG adducts have rarely if ever been observed directly in human samples using LC-MS techniques, even though sophisticated methodologies have been employed which should have had sufficient sensitivity. With this in mind, we developed a liquid chromatography electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS)methodology employing high-resolution/accurate mass analysis for detecting ultratrace levels of these adducts. These efforts are directly translatable to the development of sensitive detection of other small molecules using trap -based LC- ESI-MS/MSdetection. The developed methodology had a limit of detection (LOD) of 1 amol of BPDE N-2-dG on-column, corresponding to 1 BPDE N-2-dG adduct per 1011 nucleotides (1 adduct per 10 human lung cells) using 40,mu g of human lung DNA. To our knowledge, this is the most sensitive DNA adduct quantitation method yet reported, exceeding the sensitivity of the (32P)-postlabeling assay (similar to 1 adduct per 101 nucleotides). Twenty-nine human lung DNA samples resulted in 20 positive measurements above the LOD, with smoker and nonsmoker DNA containing 3.1 and 1.3 BPDE N-2-dG adducts per 1011 nucleotides, respectively.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available